BioHit HealthCare UK: against COVID-19 Company
Entity: BioHit HealthCare
Category: Test Kits
Description: For over 10 years BIOHIT HealthCare Ltd has supplied diagnostic tests, health products and services to improve the care of digestive diseases and ease patient management, both in the UK and worldwide. They manufacture and supply diagnostic tests that are used routinely in clinical laboratories, endoscopy units and practice clinics as well as in academic and clinical research settings. Their expertise is drawn from academic, clinical and commercial experience that enables them to deliver transformative technology, processes and pathways to the benefit of patients, healthcare providers and the economy.
Project: MutaPLEX Coronavirus kit from Immundiagnostik AG (IDK) + Epitope Diagnostics Inc's (EDI's) immunodiagnostic tests
Summary: Their new product line includes the MutaPLEX Coronavirus kit from Immundiagnostik AG (IDK) – a real-time RT-PCR assay to screen for infected individuals – and Epitope Diagnostics Inc's (EDI's) immunodiagnostic tests for IgM and IgG COVID-19 antibodies, to detect past infections.
Category: Test Kits
Description: For over 10 years BIOHIT HealthCare Ltd has supplied diagnostic tests, health products and services to improve the care of digestive diseases and ease patient management, both in the UK and worldwide. They manufacture and supply diagnostic tests that are used routinely in clinical laboratories, endoscopy units and practice clinics as well as in academic and clinical research settings. Their expertise is drawn from academic, clinical and commercial experience that enables them to deliver transformative technology, processes and pathways to the benefit of patients, healthcare providers and the economy.
Project: MutaPLEX Coronavirus kit from Immundiagnostik AG (IDK) + Epitope Diagnostics Inc's (EDI's) immunodiagnostic tests
Summary: Their new product line includes the MutaPLEX Coronavirus kit from Immundiagnostik AG (IDK) – a real-time RT-PCR assay to screen for infected individuals – and Epitope Diagnostics Inc's (EDI's) immunodiagnostic tests for IgM and IgG COVID-19 antibodies, to detect past infections.
Technology:
Test Kits
Headquarters:
United Kingdom
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership